Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Audentes
Audentes
Astellas takes $540M impairment charge over Audentes' gene therapy trial hold
Fierce Biotech
Tue, 04/27/21 - 10:47 am
Astellas
Audentes
AT132
gene therapy
Nearly a year after Audentes' gene therapy deaths, the trial continues. What happened remains a mystery
Endpoints
Wed, 04/14/21 - 09:37 am
Audentes
Astellas
gene therapy
clinical trials
Audentes CEO exits as Astellas rebrands a gene therapy buyout
BioPharma Dive
Thu, 04/1/21 - 11:01 am
Astellas
Audentes
gene therapy
M&A
Astellas Gene Therapies
Audentes sees FDA hold lifted after 3 trial deaths blighted $3B program
Fierce Biotech
Mon, 12/28/20 - 10:59 am
Audentes
Astellas
FDA
clinical trials
AT132
gene therapy
X-linked myotubular myopathy